(Q38202946)

30 August 2017

title

WIDEN: A tool for medical image management in multicenter clinical trials (English)

1 reference

multicenter clinical trial

30 August 2017

main subject

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Agostino Chiaravalloti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Orazio Schillaci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Alberto Biggi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alexandru Stancu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Piergiorgio Cerello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Anna Cavallo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Federico Fallanca

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Umberto Ficola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michele Gregianin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ugo Paolo Guerra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Andrea Gallamini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

7 April 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

355-361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24711610%20AND%20SRC:MED&resulttype=core&format=json

Molecular imaging of cancer with positron emission tomography

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Positron-emission tomography and assessment of cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Role of positron emission tomography in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

PET/CT for therapy response assessment in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

International validation study for interim PET in ABVD-treated, advanced-stage hodgkin lymphoma: interpretation criteria and concordance rate among reviewers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Cloud computing in medical imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Introduction to the ACR-NEMA DICOM standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

The Internet and clinical trials: background, online resources, examples and issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690

Routine quality control recommendations for nuclear medicine instrumentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774514525690